Live Breaking News & Updates on Julie kim

Stay informed with the latest breaking news from Julie kim on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Julie kim and stay connected to the pulse of your community

Takeda Puts Up $300M to Partner on Protagonist Drug for Rare Blood Disease

Protagonist Therapeutics' rusfertide could have preliminary data next year from its Phase 3 test in polycythemia vera. If the peptide drug wins FDA approval in this rare blood disorder, the partners will share in U.S. commercialization while Takeda is responsible for the drug in the rest of the world.

United-states , California , American , Takeda-adzynma , Dinesh-patel , Julie-kim , American-society-of-hematology , Ionis-pharmaceuticals , Protagonist-therapeutics , California-based-protagonist , American-society , Silence-therapeutics

Takeda and Protagonist Therapeutics, Inc. Enter into Worldwide License and Collaboration Agreement for Rusfertide, a Late-Stage Rare Hematology Asset

Takeda and Protagonist Therapeutics, Inc. Enter into Worldwide License and Collaboration Agreement for Rusfertide, a Late-Stage Rare Hematology Asset
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Cambridge , Cambridgeshire , United-kingdom , Japan , Osaka , Japanese , American , Ann-hematol , Dineshv-patel , Corey-davis , Megan-ostrower

Takeda (TAK) and Protagonist Therapeutics (PTGX) Enter Global License and Collaboration Agreement for Rusfertide

Takeda (TAK) and Protagonist Therapeutics (PTGX) Enter Global License and Collaboration Agreement for Rusfertide
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , American , Dineshv-patel , Julie-kim , Us-co , Drug-administration , Exchange-commission , Protagonist-therapeutics-inc , American-society-of-hematology , Nasdaq , Be-protagonist-co , Takeda-will-be-protagonist

Takeda and Protagonist Therapeutics, Inc. Enter into Worldwide License and Collaboration Agreement for Rusfertide, a Late-Stage Rare Hematology Asset

Takeda and Protagonist Therapeutics, Inc. Enter into Worldwide License and Collaboration Agreement for Rusfertide, a Late-Stage Rare Hematology Asset
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United-states , Japan , Cambridge , Cambridgeshire , United-kingdom , Osaka , American , Japanese , Ann-hematol , Stefan-klotter , Megan-ostrower , Dineshv-patel

Artificial intelligence (AI) can help developing economies diversify

Countries worldwide are racing to harness AI to make their industries more competitive in export markets and discover new areas of comparative advantage.

Germany , Mexico , India , German , Robert-koopman , Julie-kim , Keith-streir , Nikola-spatafora , Economic-diversification , Giuditta-de-prato , Robot-automation

2023: How the Long Island region kept the momentum going | Long Island Business News

2023: How the Long Island region kept the momentum going | Long Island Business News
libn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from libn.com Daily Mail and Mail on Sunday newspapers.

Taiwan , Elmont , New-york , United-states , Kentucky , Governors-island , Islandia , Manhattan , Canada , East-islip , Zucker-hillside-hospital , Beechwood

2023 holiday gift guide by Asian-owned businesses

2023 holiday gift guide by Asian-owned businesses
nwasianweekly.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nwasianweekly.com Daily Mail and Mail on Sunday newspapers.

Japan , Spain , Peru , Portugal , Sodo , Tinh-binh-dinh , Vietnam , Republic-of , Mexico , United-states , Taiwan , Mexican

Takeda launches Adzynma

Adzynma is the first recombinant ADAMTS13 enzyme replacement therapy for treating Congenital Thrombotic Thrombocytopenic Purpura.

Spero-cataland , Julie-kim , Us-thrombotic-microangiopathy-alliance , Wexner-medical-center , Ohio-state-university , Drug-administration , Microangiopathy-alliance ,